These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 15366951

  • 1. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
    McQuade P, Knight LC, Welch MJ.
    Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.
    Harris TD, Kalogeropoulos S, Nguyen T, Dwyer G, Edwards DS, Liu S, Bartis J, Ellars C, Onthank D, Yalamanchili P, Heminway S, Robinson S, Lazewatsky J, Barrett J.
    Bioconjug Chem; 2006; 17(5):1294-313. PubMed ID: 16984141
    [Abstract] [Full Text] [Related]

  • 3. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM, Beaumier P, Axworthy D, Atcher R, Fritzberg A.
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [Abstract] [Full Text] [Related]

  • 4. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 5. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
    Janssen ML, Oyen WJ, Dijkgraaf I, Massuger LF, Frielink C, Edwards DS, Rajopadhye M, Boonstra H, Corstens FH, Boerman OC.
    Cancer Res; 2002 Nov 01; 62(21):6146-51. PubMed ID: 12414640
    [Abstract] [Full Text] [Related]

  • 6. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.
    J Nucl Med; 2004 Oct 01; 45(10):1776-83. PubMed ID: 15471848
    [Abstract] [Full Text] [Related]

  • 7. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y, Zhang X, Xiong Z, Cheng Z, Fisher DR, Liu S, Gambhir SS, Chen X.
    J Nucl Med; 2005 Oct 01; 46(10):1707-18. PubMed ID: 16204722
    [Abstract] [Full Text] [Related]

  • 8. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
    Li L, Wartchow CA, Danthi SN, Shen Z, Dechene N, Pease J, Choi HS, Doede T, Chu P, Ning S, Lee DY, Bednarski MD, Knox SJ.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1215-27. PubMed ID: 15001266
    [Abstract] [Full Text] [Related]

  • 9. Use of antibody as carrier of oligomers of peptidomimetic alphavbeta3 antagonist to target tumor-induced neovasculature.
    Shin IS, Jang BS, Danthi SN, Xie J, Yu S, Le N, Maeng JS, Hwang IS, Li KC, Carrasquillo JA, Paik CH.
    Bioconjug Chem; 2007 Mar 15; 18(3):821-8. PubMed ID: 17375899
    [Abstract] [Full Text] [Related]

  • 10. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
    Riccobene TA, Miceli RC, Lincoln C, Knight Y, Meadows J, Stabin MG, Sung C.
    J Nucl Med; 2003 Mar 15; 44(3):422-33. PubMed ID: 12621010
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective targeting of adenovirus to alphavbeta3 integrins, VEGFR2 and Tie2 endothelial receptors by angio-adenobodies.
    Haisma HJ, Kamps GK, Bouma A, Geel TM, Rots MG, Kariath A, Bellu AR.
    Int J Pharm; 2010 May 31; 391(1-2):155-61. PubMed ID: 20211716
    [Abstract] [Full Text] [Related]

  • 13. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF, Ellis LM.
    Cancer Res; 2003 May 01; 63(9):2079-87. PubMed ID: 12727823
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
    Roosenburg S, Laverman P, Joosten L, Eek A, Oyen WJ, de Jong M, Rutjes FP, van Delft FL, Boerman OC.
    Bioconjug Chem; 2010 Apr 21; 21(4):663-70. PubMed ID: 20302291
    [Abstract] [Full Text] [Related]

  • 16. 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression.
    Jia B, Shi J, Yang Z, Xu B, Liu Z, Zhao H, Liu S, Wang F.
    Bioconjug Chem; 2006 Apr 21; 17(4):1069-76. PubMed ID: 16848417
    [Abstract] [Full Text] [Related]

  • 17. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.
    Paudyal B, Paudyal P, Oriuchi N, Hanaoka H, Tominaga H, Endo K.
    Cancer Sci; 2011 Jan 21; 102(1):117-21. PubMed ID: 21070475
    [Abstract] [Full Text] [Related]

  • 18. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
    Morales-Avila E, Ferro-Flores G, Ocampo-García BE, De León-Rodríguez LM, Santos-Cuevas CL, García-Becerra R, Medina LA, Gómez-Oliván L.
    Bioconjug Chem; 2011 May 18; 22(5):913-22. PubMed ID: 21513349
    [Abstract] [Full Text] [Related]

  • 19. Improved in vivo stability and tumor targeting of bismuth-labeled antibody.
    Ruegg CL, Anderson-Berg WT, Brechbiel MW, Mirzadeh S, Gansow OA, Strand M.
    Cancer Res; 1990 Jul 15; 50(14):4221-6. PubMed ID: 2364380
    [Abstract] [Full Text] [Related]

  • 20. Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein.
    Sato N, Hassan R, Axworthy DB, Wong KJ, Yu S, Theodore LJ, Lin Y, Park L, Brechbiel MW, Pastan I, Paik CH, Carrasquillo JA.
    J Nucl Med; 2005 Jul 15; 46(7):1201-9. PubMed ID: 16000290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.